Ophthalmology · Fort Worth, TX
NPI
1043237647
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4932 Overton Ridge Blvd
Fort Worth, TX, 76132
Phone (817) 423-3937
Groups this clinician bills Medicare through
Medicare paid, 2024
$424K
5,031 services
Medicare patients, 2024
811
Average age 77
Drug cost, 2024
$510K
2,059 prescriptions
Company payments, 2024
$45.69
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Harry Rosenthal Jr. was code 92134 (computerized ophthalmic imaging), 1,288 times for 516 patients. In total Harry Rosenthal Jr. billed 5,031 services in 37 codes, and Medicare paid $424K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-01-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92134 Computerized Ophthalmic Imaging | Office | 1,288 | 516 | $29.51 | $38K |
| 92014 Ophthalmological E&M | Office | 746 | 630 | $88.51 | $66K |
| 99213 Office E&M - Established | Office | 477 | 200 | $67.38 | $32K |
| 67028 Intravitreal Injection | Office | 428 | 126 | $85.34 | $37K |
| 99214 Office E&M - Established | Office | 370 | 172 | $94.88 | $35K |
| 92250 Angiography | Office | 302 | 209 | $28.35 | $8,562 |
| J9035 Injection, bevacizumab, 10 mg | Office | 225 | 85 | $56.02 | $13K |
| J0178 Injection, aflibercept, 1 mg | Office | 154 | 26 | $656.25 | $101K |
| J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 133 | 11 | $161.19 | $21K |
| 92133 Computerized Ophthalmic Imaging | Office | 82 | 75 | $24.36 | $1,997 |
| 92004 Ophthalmological E&M | Office | 77 | 77 | $110.54 | $8,511 |
| J2781 Injection, pegcetacoplan, intravitreal, 1 mg | Office | 38 | 12 | $104.44 | $3,969 |
| 92083 Vision, Hearing, and Speech Services | Office | 31 | 30 | $45.61 | $1,414 |
| 99204 Office E&M - New | Office | 30 | 30 | $125.89 | $3,777 |
| 92235 Angiography | Office | 14 | 14 | $119.73 | $1,676 |
By year: 2022 $455K for 6,092 services; 2023 $431K for 5,199 services; 2024 $424K for 5,031 services.
Medicare prescription drug claims, 2024
In 2024, the drug Harry Rosenthal Jr. prescribed most often to Medicare patients was Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat), with 581 prescriptions and refills. In total Harry Rosenthal Jr. wrote 2,059 Medicare prescriptions that cost $510K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 581 | 1,266 | 157 | $7,329 |
| Latanoprost Generic | 540 | 1,238 | 157 | $5,055 |
| Brimonidine Tartrate Generic | 158 | 311 | 40 | $2,678 |
| Lumigan Bimatoprost | 107 | 186 | 25 | $47K |
| Prednisolone Acetate Generic | 85 | 134 | 56 | $4,046 |
| Syfovre Pegcetacoplan/Pf | 83 | 151 | 22 | $182K |
| Timolol Maleate Generic | 64 | 144 | 19 | $763 |
| Eylea Aflibercept | 52 | 52 | 32 | $101K |
| Ketorolac Tromethamine Generic | 49 | 97 | 18 | $2,289 |
| Brinzolamide Generic | 38 | 72 | Under 11 | $4,928 |
| Ozurdex Dexamethasone | 29 | 81 | 12 | $48K |
| Moxifloxacin Moxifloxacin Hcl | 26 | 26 | 22 | $635 |
| Travoprost Generic | 24 | 42 | Under 11 | $2,212 |
| Beovu Brolucizumab-Dbll | 22 | 41 | Under 11 | $44K |
| Prolensa Bromfenac Sodium | 22 | 33 | Under 11 | $12K |
Brand drugs: 784 claims; generic drugs: 1,275 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Harry Rosenthal Jr. $45.69 ($45.69 in general payments such as food, travel and fees) from 2 companies. The largest payer was Alimera Sciences, Inc. with $28.5.
| Company | Payments | Amount |
|---|---|---|
| Alimera Sciences, Inc. | 1 | $28.5 |
| Apellis Pharmaceuticals, Inc. APLS | 1 | $17.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.